Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely made TPD strategies. During this critique, we center on both equally preclinical experiments and medical trials to deliver a comprehensive summary of the safety and medical success of PROTACs and MGDs in hematologic malignancies over the past 20 https://md-22489123.losblogos.com/31040342/about-u-73122